Literature DB >> 23994475

RAG2's acidic hinge restricts repair-pathway choice and promotes genomic stability.

Marc A Coussens1, Rebecca L Wendland, Ludovic Deriano, Cory R Lindsay, Suzzette M Arnal, David B Roth.   

Abstract

V(D)J recombination-associated DNA double-strand breaks (DSBs) are normally repaired by the high-fidelity classical nonhomologous end-joining (cNHEJ) machinery. Previous studies implicated the recombination-activating gene (RAG)/DNA postcleavage complex (PCC) in regulating pathway choice by preventing access to inappropriate repair mechanisms such as homologous recombination (HR) and alternative NHEJ (aNHEJ). Here, we report that RAG2's "acidic hinge," previously of unknown function, is critical for several key steps. Mutations that reduce the hinge's negative charge destabilize the PCC, disrupt pathway choice, permit repair of RAG-mediated DSBs by the translocation-prone aNHEJ machinery, and reduce genomic stability in developing lymphocytes. Structural predictions and experimental results support our hypothesis that reduced flexibility of the hinge underlies these outcomes. Furthermore, sequence variants present in the human population reduce the hinge's negative charge, permit aNHEJ, and diminish genomic integrity.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23994475      PMCID: PMC4008148          DOI: 10.1016/j.celrep.2013.07.041

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  52 in total

Review 1.  Comparative architecture of transposase and integrase complexes.

Authors:  P A Rice; T A Baker
Journal:  Nat Struct Biol       Date:  2001-04

2.  Intermediates in V(D)J recombination: a stable RAG1/2 complex sequesters cleaved RSS ends.

Authors:  J M Jones; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination.

Authors:  Chia-Lun Tsai; Anna H Drejer; David G Schatz
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

4.  RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination.

Authors:  Gregory S Lee; Matthew B Neiditch; Sandra S Salus; David B Roth
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

5.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.

Authors:  M A Oettinger; D G Schatz; C Gorka; D Baltimore
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

6.  The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism.

Authors:  B A Malynn; T K Blackwell; G M Fulop; G A Rathbun; A J Furley; P Ferrier; L B Heinke; R A Phillips; G D Yancopoulos; F W Alt
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

7.  Definition of a core region of RAG-2 that is functional in V(D)J recombination.

Authors:  M J Sadofsky; J E Hesse; M Gellert
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

8.  Analysis of regions of RAG-2 important for V(D)J recombination.

Authors:  C A Cuomo; M A Oettinger
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

9.  The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination.

Authors:  Z Li; T Otevrel; Y Gao; H L Cheng; B Seed; T D Stamato; G E Taccioli; F W Alt
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

10.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.

Authors:  T Blunt; N J Finnie; G E Taccioli; G C Smith; J Demengeot; T M Gottlieb; R Mizuta; A J Varghese; F W Alt; P A Jeggo; S P Jackson
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

View more
  20 in total

Review 1.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

2.  Restoration of ATM Expression in DNA-PKcs-Deficient Cells Inhibits Signal End Joining.

Authors:  Jessica A Neal; Yao Xu; Masumi Abe; Eric Hendrickson; Katheryn Meek
Journal:  J Immunol       Date:  2016-02-26       Impact factor: 5.422

3.  The RAG-2 Inhibitory Domain Gates Accessibility of the V(D)J Recombinase to Chromatin.

Authors:  Alyssa Ward; Gita Kumari; Ranjan Sen; Stephen Desiderio
Journal:  Mol Cell Biol       Date:  2018-07-16       Impact factor: 4.272

Review 4.  V(D)J Recombination: Mechanism, Errors, and Fidelity.

Authors:  David B Roth
Journal:  Microbiol Spectr       Date:  2014-12

Review 5.  Relating sequence encoded information to form and function of intrinsically disordered proteins.

Authors:  Rahul K Das; Kiersten M Ruff; Rohit V Pappu
Journal:  Curr Opin Struct Biol       Date:  2015-04-02       Impact factor: 6.809

6.  An autoregulatory mechanism imposes allosteric control on the V(D)J recombinase by histone H3 methylation.

Authors:  Chao Lu; Alyssa Ward; John Bettridge; Yun Liu; Stephen Desiderio
Journal:  Cell Rep       Date:  2014-12-24       Impact factor: 9.423

Review 7.  DNA Damage Response and Repair in Adaptive Immunity.

Authors:  Sha Luo; Ruolin Qiao; Xuefei Zhang
Journal:  Front Cell Dev Biol       Date:  2022-05-17

Review 8.  Structural insights into the evolution of the RAG recombinase.

Authors:  Chang Liu; Yuhang Zhang; Catherine C Liu; David G Schatz
Journal:  Nat Rev Immunol       Date:  2021-10-21       Impact factor: 108.555

9.  The ATM Kinase Restrains Joining of Both VDJ Signal and Coding Ends.

Authors:  Katheryn Meek; Yao Xu; Caleb Bailie; Kefei Yu; Jessica A Neal
Journal:  J Immunol       Date:  2016-08-29       Impact factor: 5.422

Review 10.  Riches in RAGs: Revealing the V(D)J Recombinase through High-Resolution Structures.

Authors:  Karla K Rodgers
Journal:  Trends Biochem Sci       Date:  2016-11-05       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.